Avalere Adds New Expert in Vaccines

  • This page as PDF

Summary

Dr. Angela Shen Joins the Firm
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Dr. Angela Shen will be joining Avalere’s vaccines team as a senior adviser. She has worked extensively in the public sector in scientific, technical, and policy positions. Most recently, she was the senior science policy adviser at the US Department of Health & Human Services National Vaccine Program Office. Prior to that, she was the senior public health adviser for vaccines and immunizations at USAID in the Global Health Bureau. She also served at the US Food and Drug Administration licensing a number of biologic products including vaccines and at the US Centers for Disease Control and Prevention as a Presidential Management Fellow and an Associated Schools of Public Health Research Fellow. She is a widely published researcher and holds a faculty appointment at the Drexel University Dornsife School of Public Health.

“Angela is one of the most nationally respected vaccine thought leaders. We saw the strengthening over the past decade of an adult immunization platform in large part thanks to her leadership,” said Richard Hughes, principal and vaccines leader at Avalere. “She joins our team at a time when we are addressing a lot of critical barriers for a robust pipeline of adult vaccines.”

To receive Avalere updates, connect with us.

2025: Opportunity Through Uncertainty Sign Up for Our 2025 Healthcare Industry Outlook Webinar

January 23, 11 AM ET

Learn More
Register Now
From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top